Xyrem

Results: 56



#Item
11South Dakota State Employee Benefits Program Non-Covered Products under Pharmacy Benefits  Adasuve®  Aptiom®  Aricept® 23mg (only 23mg)

South Dakota State Employee Benefits Program Non-Covered Products under Pharmacy Benefits  Adasuve®  Aptiom®  Aricept® 23mg (only 23mg)

Add to Reading List

Source URL: benefits.sd.gov

Language: English - Date: 2014-10-22 11:40:28
12Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs Cataloguing FDA’s Flexibility in Regulating Therapies for Persons with Rare Disorders by Frank J. Sasinowski, M.S., M.P.H., J.D.1 Chairman of the Bo

Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs Cataloguing FDA’s Flexibility in Regulating Therapies for Persons with Rare Disorders by Frank J. Sasinowski, M.S., M.P.H., J.D.1 Chairman of the Bo

Add to Reading List

Source URL: rarediseases.org

Language: English - Date: 2012-12-18 11:57:21
13Narcolepsy Summary Report

Narcolepsy Summary Report

Add to Reading List

Source URL: www.fda.gov

Language: English
14Orphan Drugs The term

Orphan Drugs The term "orphan drug" refers to a product that treats a rare disease affecting fewer than 200,000 Americans. The Orphan Drug Act was signed into law on January 4, 1983. Since the Orphan Drug Act passed, ove

Add to Reading List

Source URL: humansubjects.stanford.edu

Language: English - Date: 2006-11-02 15:22:31
15Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs Cataloguing FDA’s Flexibility in Regulating Therapies for Persons with Rare Disorders by Frank J. Sasinowski, M.S., M.P.H., J.D.1 Chairman of the Bo

Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs Cataloguing FDA’s Flexibility in Regulating Therapies for Persons with Rare Disorders by Frank J. Sasinowski, M.S., M.P.H., J.D.1 Chairman of the Bo

Add to Reading List

Source URL: nordphysicianguides.org

Language: English - Date: 2013-06-21 13:23:45
16Orphan Drug Analysis[removed]xlsx

Orphan Drug Analysis[removed]xlsx

Add to Reading List

Source URL: info.evaluategroup.com

Language: English - Date: 2014-10-17 14:06:35
17

PDF Document

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2003-10-21 17:39:06
18To:  MaineCare Providers From:

To: MaineCare Providers From:

Add to Reading List

Source URL: mainecarepdl.org

Language: English - Date: 2013-03-08 08:18:28
19Psychiatry / Health / Nootropics / Stimulants / Narcolepsy / Excessive daytime sleepiness / Xyrem / Polysomnography / Obstructive sleep apnea / Sleep disorders / Medicine / Sleep

PROV.16 Form # 20710 R: 7.11 State of Maine Department of Health & Human Services

Add to Reading List

Source URL: mainecarepdl.org

Language: English - Date: 2012-03-19 13:42:50
20South Dakota Risk Pool Plan FY14 Non Covered Products Under Pharmacy Benefits  Aricept® 23mg (only 23mg)   Brand name oral

South Dakota Risk Pool Plan FY14 Non Covered Products Under Pharmacy Benefits  Aricept® 23mg (only 23mg)  Brand name oral

Add to Reading List

Source URL: riskpool.sd.gov

Language: English - Date: 2013-07-01 08:33:15